Parkinson patients can be apathetic without depressionJuly 11, 2006ST. Paul, Minn. — People with Parkinson disease can be apathetic without being depressed, and apathy may be a core feature of the disease, according to a study published in the July 11, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology. Apathy is a mental state characterized by a loss of motivation, loss of interest, and loss of effortful behavior. In apathy, the mood is neutral and there is a sense of indifference. In depression, the mood is negative and there is emotional suffering. Because apathy and depression share some of the same symptoms, the disorders can be misdiagnosed. "This study shows that it's important to screen for both apathy and depression so patients can be treated appropriately," said study author Lindsey Kirsch-Darrow, MS, of the University of Florida in Gainesville. "It will also be important to educate family members and caregivers about apathy to help them understand that it is a characteristic of Parkinson disease. Apathetic behavior is not something the patient can voluntarily control, and it is not laziness or the patient trying to be difficult — it is a symptom of Parkinson disease." The study compared 80 people with Parkinson disease to 20 people with dystonia, another movement disorder. The researchers hypothesized that apathy would occur more often in people with Parkinson disease, because the disease affects areas of the brain in the frontal cortex that are involved in non-motor activities, whereas dystonia affects areas mainly involved with movement. Of those with Parkinson disease, 51 percent had apathy, compared to 20 percent of those with dystonia. Apathy with no depression occurred in 29 percent of those with Parkinson disease and none of those with dystonia. The rate of depression was the same in both groups. Treatments for depression and apathy in people with Parkinson disease are still being evaluated. The current criteria for diagnosing depression may not be appropriate for people with Parkinson disease, according to neurologist Irene Richard, MD, of the University of Rochester in New York, who wrote an editorial accompanying the study. "A person with Parkinson disease might be diagnosed with minor depression based solely on the presence of apathy," she said. "The recognition that apathy can be present without depression is important so that we do not inappropriately diagnose and treat a depressive disorder that is not present." The study is consistent with guidelines issued recently by the American Academy of Neurology recommending that all people with Parkinson disease be screened for and treated for depression, which can affect their quality of life and how well they function. American Academy of Neurology |
|||||||||||||||||||||
| Related Parkinson Disease Current Events and Parkinson Disease News Articles A balancing act in Parkinson's disease: Phosphorylation of alpha-synuclein Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Rochester-led Parkinson's study pays off again, 2 decades later Parkinson disease progresses more slowly in patients who have higher levels of urate, a chemical that at very high level is associated with gout, scientists have found. Pesticide exposure found to increase risk of Parkinson's disease The fertile soil of California's Central Valley has long made it famous as one of the nation's prime crop-growing regions. But it's not just the soil that allows for such productivity. Crops like potatoes, dry beans and tomatoes have long been protected from bugs and weeds by the fungicide maneb and the herbicide paraquat. Immune cells contribute to the development of Parkinson's disease Parkinson disease is a neurodegenerative disorder that impairs movement, balance, speech, and other functions. It is characterized by the loss of nerves in the brain that produce a substance known as dopamine. Lessons from yeast: A possible cure for Parkinson's disease? Parkinson disease (PD) is a debilitating and lethal neurodegenerative disease, for which there is currently no cure. It is caused by the progressive loss of nerve cells that produce the chemical dopamine and is characterized by the accumulation of abnormal aggregates of a protein called alpha-syn in these dopaminergic nerve cells. New Study Shows that Fetal Cells Transplanted into the Brain to Treat Parkinson's Disease May Not Function Long Term Neurons grafted into the brain of a patient with Parkinson's disease fourteen years ago have developed Lewy body pathology, the defining pathology for the disease, according to research by Jeffrey H. Kordower, PhD, and associates and published in the April 6 issue of Nature Medicine. Family study bolsters link between pesticides and Parkinson's For the first time, the association between Parkinson's disease and exposure to pesticides has been shown in patients with the neurological disorder compared with their unaffected relatives, according to a study in the online open access journal BMC Neurology. Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition. PINK1 protects from Parkinson's Parkinson disease (PD) is a common neurodegenerative disease characterized by the selective loss of midbrain dopaminergic neurons. Researchers identify protein pathway involved in Parkinson disease development Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. More Parkinson Disease Current Events and Parkinson Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||